XTL Biopharmaceuticals Ltd
Company Profile
Business description
XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren’s syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.
Contact
26 Ben-Gurion Street
Ramat Gan 5112001
ISRT: +972 36116600
E: info@xtlbio.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
4
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
---|---|---|---|
All Ordinaries | 8,191.90 | 22.90 | -0.28% |
CAC 40 | 7,425.26 | 72.96 | 0.99% |
DAX 40 | 18,443.56 | 141.66 | 0.77% |
Dow JONES (US) | 40,968.86 | 623.45 | 1.55% |
FTSE 100 | 8,270.84 | 89.37 | 1.09% |
HKSE | 17,196.96 | 247.34 | -1.42% |
NASDAQ | 16,881.75 | 190.91 | 1.14% |
Nikkei 225 | 36,215.75 | 175.72 | -0.48% |
NZX 50 Index | 12,621.62 | 6.11 | 0.05% |
S&P 500 | 5,477.26 | 68.84 | 1.27% |
S&P/ASX 200 | 7,988.10 | 25.30 | -0.32% |
SSE Composite Index | 2,736.49 | 29.32 | -1.06% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
---|---|---|---|
Bowen Coking Coal Ltd BCB | 0.01 | 0.00 | -18.18% |
Elanor Commercial Property Fund ECF | 0.61 | 0.01 | -0.82% |
Imugene Ltd IMU | 0.05 | 0.00 | -1.85% |
Telstra Group Ltd TLS | 3.92 | 0.01 | -0.25% |
Red 5 Ltd RED | 0.29 | 0.01 | -3.33% |
Pilbara Minerals Ltd PLS | 2.41 | 0.00 | 0.00% |
Sayona Mining Ltd SYA | 0.02 | 0.00 | -4.35% |
Latin Resources Ltd LRS | 0.17 | 0.01 | 3.13% |
Pointsbet Holdings Ltd PBH | 0.57 | 0.06 | 11.76% |
Liontown Resources Ltd LTR | 0.62 | 0.03 | 4.20% |